Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Sitemap: https://www.cabometyxhcp.com/sitemap.xml User-agent: * Disallow: /user/ Disallow: /taxonomy/ Disallow: /cohesionapi/ Disallow: /ajax_machine_name/ Disallow: /search/node/ Disallow: /jsonapi/ |
Title | CABOMETYX® (cabozantinib) is a multi-indication cancer |
Description | A 1L aRCC combination treatment that offers a balance of CABOMETYX is a multi-indication cancer treatment FDA-approved for 1L & 2L aRCC, 2L HCC and 2L DTC. See Important Safety |
Keywords | N/A |
WebSite | cabometyxhcp.com |
Host IP | 44.239.158.13 |
Location | United States |
Site | Rank |
US$10,058,123
Last updated: 2022-08-21 07:56:50
cabometyxhcp.com has Semrush global rank of 1,052,314. cabometyxhcp.com has an estimated worth of US$ 10,058,123, based on its estimated Ads revenue. cabometyxhcp.com receives approximately 1,160,553 unique visitors each day. Its web server is located in United States, with IP address 44.239.158.13. According to SiteAdvisor, cabometyxhcp.com is safe to visit. |
Purchase/Sale Value | US$10,058,123 |
Daily Ads Revenue | US$9,285 |
Monthly Ads Revenue | US$278,533 |
Yearly Ads Revenue | US$3,342,392 |
Daily Unique Visitors | 77,371 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
cabometyxhcp.com. | A | 300 | IP: 44.239.158.13 |
cabometyxhcp.com. | NS | 86400 | NS Record: ns-784.awsdns-34.net. |
cabometyxhcp.com. | NS | 86400 | NS Record: ns-1358.awsdns-41.org. |
cabometyxhcp.com. | NS | 86400 | NS Record: ns-1555.awsdns-02.co.uk. |
cabometyxhcp.com. | NS | 86400 | NS Record: ns-476.awsdns-59.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 1 aspmx.l.google.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 10 alt3.aspmx.l.google.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 10 alt4.aspmx.l.google.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 15 lvmqs33td5xacnglhmbqlfhw5dohul5b3tu56drl2xqzyz7de23q.mx-verification.google.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 5 alt1.aspmx.l.google.com. |
cabometyxhcp.com. | MX | 1800 | MX Record: 5 alt2.aspmx.l.google.com. |
cabometyxhcp.com. | TXT | 300 | TXT Record: f4vtm463l5g65v4co2mscnk8nb |
cabometyxhcp.com. | TXT | 300 | TXT Record: google-site-verification=WJiVZod_TCpPfOy3vpHFMcAEtNeOuXko454FENz7cmk |
Skip to main content This site is intended for US Healthcare professionals only Important Safety Information Prescribing Information For Patients & Caregivers Contact A Rep aRCC Advanced Renal Cell Carcinoma 1L Combination 1L Monotherapy 2L Monotherapy HCC Hepatocellular Carcinoma Cancer Type Back aRCC HCC DTC Cancer Type aRCC HCC DTC Indications aRCC Advanced Renal Cell Carcinoma 1L Combination 1L Monotherapy 2L Monotherapy HCC Hepatocellular Carcinoma Cancer Type Back aRCC HCC DTC Cancer Type aRCC HCC DTC Mechanism of Action Access Resources Important Safety Information Prescribing Information For Patients & Caregivers Contact A Rep A 1L aRCC combination treatment that offers a balance of data View Data † vs sunitinib in patients with previously untreated aRCC. Primary analysis OS results: 40% reduction in risk of death with CABOMETYX + OPDIVO vs sunitinib (HR=0.60; 98.89% CI: 0.40-0.89, P =0.001); median OS was not reached in either arm. 1,4 ‡ The primary endpoint was PFS (16.6 |
HTTP/1.1 301 Moved Permanently Date: Mon, 20 Dec 2021 08:54:18 GMT Server: Apache/2.4.46 () Location: https://www.cabometyxhcp.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 content-type: text/html content-length: 164723 x-amz-id-2: P2idxa1T5A8dHjtzC0sH9J5g8ndcKYNHqsVn5xiAFjWcF50GWJJcIYYs4Qfu5ymQme892vF/nnU= x-amz-request-id: N5XHMRZFZ6Z72H59 date: Sun, 19 Dec 2021 09:15:46 GMT last-modified: Thu, 09 Dec 2021 16:22:44 GMT etag: "f6566a86ae989a614a149b8f301861e0" cache-control: max-age=86400,public accept-ranges: bytes server: AmazonS3 vary: Accept-Encoding set-cookie: ajs_anonymous_id=%229ef3fc72-d664-4f2b-8b65-72b5a6e5a193%22; Max-Age=31536000; Domain=cabometyxhcp x-cache: Hit from cloudfront via: 1.1 2435a43ad9e6173e7352a49a09dd01b0.cloudfront.net (CloudFront) x-amz-cf-pop: EWR53-C3 x-amz-cf-id: 6SsufNxpx90Kqcs8NM_IyuOjq_BTcVAqkuPHASVpaqzjw7GwzJxylA== age: 85112 |
Domain Name: CABOMETYXHCP.COM Registry Domain ID: 2194351840_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-12-05T01:13:00Z Creation Date: 2017-11-30T20:56:58Z Registry Expiry Date: 2023-11-30T20:56:58Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1358.AWSDNS-41.ORG Name Server: NS-1555.AWSDNS-02.CO.UK Name Server: NS-476.AWSDNS-59.COM Name Server: NS-784.AWSDNS-34.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-23T07:25:59Z <<< |